Plain-English translation of NCT06274034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This pilot study explored whether the MUSE S headband—a wearable device that pairs with a smartphone app to guide meditation—could help breast cancer survivors reduce anxiety and improve sleep. Participants wore the headband to bed each night and used the meditation app during the day, over an 8-week period. The research team wanted to understand how often people actually used the device, whether it was practical to use, and whether it genuinely helped with these common side effects of cancer treatment.
Many breast cancer survivors struggle with anxiety and insomnia during or after treatment, and existing medications don't work for everyone. This trial was designed to explore whether a non-drug approach using guided meditation and real-time brain feedback could be a helpful, accessible tool for managing these symptoms at home.
You would wear the MUSE S headband to bed every night for 8 weeks and use the paired smartphone or tablet app to do guided meditation for at least 5 minutes each day during waking hours. The headband provides real-time feedback to help you focus during meditation. Throughout the study, you would complete assessments to track your anxiety and sleep quality, allowing researchers to see whether this approach made a difference for you.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States